Loading clinical trials...
Loading clinical trials...
Health-Related Quality of Life in Two Pathways for Newly Diagnosed Open Angle Glaucoma and Ocular Hypertension: an Unmasked, Multi-centre, Randomised Controlled Trial of Initial Selective Laser Trabeculoplasty Versus Medical Therapy
Conditions
Interventions
Primary Selective Laser Trabeculoplasty Treatment Pathway
Primary Medical Treatment Pathway
Locations
1
United Kingdom
Moorfields Eye Hospital
London, United Kingdom
Start Date
October 1, 2012
Primary Completion Date
December 25, 2017
Completion Date
December 25, 2017
Last Updated
January 10, 2018
NCT07390890
NCT07358650
NCT05902871
NCT07218796
NCT07119580
NCT07076303
Lead Sponsor
Moorfields Eye Hospital NHS Foundation Trust
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions